Podcasts about viiv healthcare

In this MM+M Fast Break, reporter Heerea Rikhraj talks with Bithiah Lafontant, director of corporate communications at ViiV Healthcare, about the impact of HIV on young people as well as the importance of providing resources for HIV prevention and linkage to care.  Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical role of real-world evidence in HIV treatment and prevention. While clinical trials establish the safety and efficacy of new therapies, real-world data help bridge the gap between these highly controlled environments and patient care in the real world. Buzón explains that collecting long-term data is essential, especially for lifelong conditions like HIV. Not only do real-world studies track how medicines perform over longer periods of time than clinical trials, they include a broader range of people, revealing potential side effects not seen in trials and ensuring long-term effectiveness for the different people who can be impacted by HIV. Beyond the science, Buzón shares how his father was a pioneer in Spain’s early response to the HIV epidemic, and why, inspired by his father’s dedication, he continues to advocate for compassionate, evidence-based care. For those interested in the evolving landscape of HIV treatment and prevention and the power of real-world data in shaping better health outcomes, this episode is a must-listen. Tune in to The Top Line to hear Buzón’s expert insights and personal perspective.See omnystudio.com/listener for privacy information.

This is Nneka's second appearance on The HIV Podcast! We talk about HIV and condom use, why white women living with HIV are so marginalised and why we can say "always" and "never" when it comes to the science behind U=U! Grab a cuppa and get listeningNneka Nwokolo is Head of Global Patient Affairs at ViiV Healthcare and an honorary consultant HIV physician at Chelsea and Westminster Hospital in London.News links https://www.hse.ie/eng/about/our-health-service/making-it-better/new-hse-campaign-to-address-hiv-stigma-in-ireland.htmlAoife was diagnosed with HIV in Australia in 2020: ‘He was unknowingly positive. We had no idea' – The Irish TimesInnovative HIV Testing Expanded in Liverpool | Invest Liverpool Hosted on Acast. See acast.com/privacy for more information.

Our podcast tonight is in observance of Transgender Day of Remembrance. Mallery Jenna Robinson is an Afro-Caribbean, transgender woman and an advocate for transgender and HIV healthcare in Los Angeles and California. She began acting at 16, starring as Tituba in The Crucible and went on to appear in A Raisin in the Sun and The Scarlet Letter. She taught middle and high school science and history from 2014 to 2019, co-leading the drama club and creating impactful plays. Mallery's work includes producing the award-winning film Two Eyes and starring in Tales of the Trancestors and TransLations. She hosts A Hateful Homicide, a true crime podcast on violence against transgender people, and provides Transgender Empathy Trainings (TET Talks) for organizations like Sony and LA County. Additionally, she's a model, singer, and subject of the documentary The Manifest of Mallery. Mallery's podcast is www.thehatefulhomocide.net. Some resources provided on this podcast: GILEAD - https://www.gileadadvancingaccess.com/ Viiv Healthcare: https://viivhealthcare.com/ Gender affirming care - Plume: https://getplume.co/

Our quest to spread the U=U word continues with this special World AIDS Day episode, featuring the incredibly knowledgeable Dr Nneka Nwokolo, a passionate advocate of spreading the message of U=U, Head of Patient Engagement at ViiV Healthcare as well as an Honorary Consultant HIV Physician at Chelsea and Westminster Hospital, London. Get the U=U digital download here - TVPS Hosted on Acast. See acast.com/privacy for more information.

Jobshare Stories : Hilary Mason and Sarah Rodgers - Finance Directors at Viiv Healthcare (part of GSK) Hilary and Sarah are seasoned finance professionals who have been working as a jobshare for just over a year.  In this episode, they talk to us about the process they have recently been through to successfully apply for an secure a role as Finance Director as a jobshare in an open recruitment process.  Hear about the strategies they employed to be successful in securing this role and the benefits they and the company are now experiencing as a result of the jobshare. #Jobshare #FlexibleWorking #JobshareRecruitment #TalentAttraction #FlexibleWorkingWorks #PowerPartTimers

In early November, the Style and Spirit Exhibition was opened at the David Roche Gallery to explore the life and design ethos of an important but forgotten style icon while highlighting how HIV stigma contributed to his erasure. Chester Weinberg was the first fashion designer to die of AIDS related illness in 1985. Despite his importance and the prominence of his work, HIV stigma saw Chester literally written out of history books. In this episode of WWW, we'll head to the exhibition's opening and hear from co-curators Skye Bartlett and Timothy Roberts. We'll also hear from Ian Hunter MLC, who helped found the South Australian AIDS Action Committee in the mid 1980s. Ann Maccarrone, Community Engagement and Partnerships Manager at ViiV Healthcare was there and speaks with Jack about the evening. We also hear from community groups at Picnic in the Park, which is part of Feast Festival, Adelaide's LGBTIQA+ Arts and Cultural Festival. Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at thorneharbour.org and in South Australia at samesh.org.au.

This week, Jean-Bernard Simeon, Senior Vice President and Head, ViiV Healthcare Europe, sits down with the EMJ GOLD team to share his thoughts on the current landscape for patients with HIV in Europe.   Together, JB and Jade explore the UNAIDS roadmap to end the HIV epidemic by 2030, the barriers faced by people living with HIV in Europe, stigmas still surrounding the condition and much more.   

Like its labs—tucked away at the far end of a Branford research park—ViiV Healthcare's accomplishments may not be well known. But the company is an authentic Connecticut success, with a story that needs to be told. ViiV and its cutting-edge R&D to treat and someday to cure HIV because the company has had such a profound impact on so many lives. ViiV head of drug discovery Dr. Umesh Hanumegowda joined the CBIA BizCast for a conversation with CBIA Bioscience Growth Council executive director Paul Pescatello. Few of us realize that in the wake of the chaos and tragedy of the 1980s AIDS epidemic, some of the most consequential research into HIV—the virus that causes AIDS—occurred in Connecticut. Connecticut scientists were among the first to identify and find effective treatments for HIV. HIV is so devastating because it is, first, a virus and therefore almost indescribably small—one human cell is 100 to 1000 times larger than a virus. And viruses are wily and zombie-like, inserting themselves into a host's cells and then taking over the cell's protein synthesis pathways to replicate. HIV is uniquely threatening because it destroys the immune system, the very mechanism our bodies use to fight infection. “It's a tough virus, a challenging virus,” Hanumegowda described. “It's a sneaky virus, because it knows how to integrate, mutate and hide.” Yale University research produced some of the first effective HIV medications. Building on the work of Yale scientists, Bristol-Myers Squibb's Wallingford labs became a center for the development of the first antiretro-viral treatments. In many ways the intellectual heir to the rich Connecticut history of HIV R&D is ViiV. Founded in 2009, ViiV is in the forefront of HIV research. The company was the first to introduce the second generation HIV integrase inhibitor, now the backbone of HIV treatment. ViiV's HIV treatments suppress HIV to undetectable levels, dramatically improving the lives of HIV patients but also preventing transmission to others. ViiV is also a leader in pre-exposure medications to prevent HIV infection. ViiV's pre-exposure medications stop HIV from taking hold of a cell. They act as a catalyst to help the body produce antibodies which block the enzyme needed by the virus to replicate and spread throughout the body. Hanumegowda chose to make HIV and ViiV the focus of his career. ViiV has a “state of the art research lab right here in Connecticut,” he said. “And HIV is challenging, and I like a tough challenge.” Another factor in Hanumegowda's professional choices was the fact that “HIV disproportionately affects particular communities.” “There is a socio-economic aspect to the disease,” he said. “There is a deep stigma associated with HIV, and I feel this is a population I can help.” Will there be a cure for HIV? Hanumegowda is confident there will be. The cure could take the form of a vaccine, or “a combination of medicines and strategies.” One such strategy is the Initiative to End HIV by 2030. Among other measures, the initiative is about using testing and identifying barriers to treatment to combat HIV. Its goals are simple: diagnose, treat, prevent, and respond. It is a public-private partnership, built on collaboration with federal and state public health agencies and the business community. CBIA has signed on, pledging to make its employees and members more aware of how to prevent and treat HIV. As to ViiV, the company plans to stay focused. Hanumegowda emphasized that ViiV has “demonstrated that staying focused will fetch us the right results.” “So, we are in it till HIV and AIDS aren't,” he said. Related Links: ViiV Healthcare Website: https://viivhealthcare.com/ LinkedIn: https://www.linkedin.com/company/viiv-healthcare/ U.S. Business Action to End HIV: https://www.healthaction.org/endhiv CBIA Website: https://www.cbia.com/ LinkedIn: https://www.linkedin.com/company/cbia/ Paul Pescatello on X: https://twitter.com/CTBio

Dr Nneka Nwokolo is an expert in HIV and menopause, women's sexual and reproductive health, contraception, and more. She is the Global Head of Patient Affairs at ViiV Healthcare and is committed to being at the forefront of raising awareness and understanding of little-discussed but important issues, helping people to live their healthiest lives. Jack and Joel speak with Nneka about: What menopause is, the symptoms, and when it happens Treatment options for menopause, and why some are over- or under-prescribed How HIV and menopause change in the presence of the other Some common experiences that women living with HIV face when seeking a diagnosis and treatment for menopause, and more Ann Maccarrone, ViiV Healthcare's Community Engagement & Partnerships Manager also joins us as we discuss the recent ASHM and IUSTI Conferences. Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at thorneharbour.org and in South Australia at samesh.org.au.

ViiV Healthcare's Head of R&D, Dr. Kimberly Smith, meets with Bloomberg Intelligence senior analyst John Murphy to discuss the evolution of HIV therapy since the 1990s, what she sees as providing the next steps of treatment innovation and how close science may be to a cure. A wide-ranging discussion in this episode also includes topics such as drug access, pricing and clinical trial diversity.See omnystudio.com/listener for privacy information.

In the most recent episode of Real Chicks Rock!® Presents Real Discussions, I have an exciting conversation with special guest and friend Ramon Rawsoul as he and his team celebrate a significant milestone: the 20th anniversary of House in the Park, a beloved event in Atlanta's community. Ramon shares stories from the past, including the event's start at Candler Park and its growth into a larger gathering at Grant Park. The shift in the energy of the attendees over the years – from a small start to accommodating thousands – speaks volumes about the community's affection for this gathering and House Music.   As we get ready for this year's celebration, a focal point of our conversation is the introduction of a new stage, made possible by a sponsorship with ViiV Healthcare, which promises an exciting addition to this year's lineup. We discuss the inclusion of diverse performers, ensuring that fans of all genres feel welcomed and engaged throughout the day. Additionally, we touch on the variety of food options available and the incredible sense of community that permeates the event.   The anticipation for this year's event is about more than just reminiscing; it's about creating new memories together. It aims to be yet another unforgettable experience in the heart of Atlanta's vibrant culture.   Special Thanks to my guest, Ramon Rawsoul. Are you subscribed to the podcast? Subscribe so you never miss an episode. https://link.chtbl.com/a5-G7mfx Please rate, comment, share, and download your favorite episodes.  Subscribe to YouTube: https://www.youtube.com/c/realchicksrock Facebook - https://www.facebook.com/RealChicksRock1 Twitter - https://twitter.com/RealChicksRock1 Instagram - https://www.instagram.com/realchicksrock Pinterest - https://www.pinterest.com/rcr012/ Website: www.RealChicksRock.com Radio Station: www.StatusNetwork.net   Kevin Hyman performed music for Kemit Muzik, LLC. The song is titled Still I Rise (The Lounge Lizards Bootleg Mix (Copyright permission granted)

From the 2024 International AIDS Conference in Munich, Germany, Cal brings us stories from the AIDS Global Village including: Louisa from northern Germany speaking about their work in reaching vulnerable populations offering counselling and testing via their mobile testing van Yianny from Tackle HIV which educates young people on HIV, and sexual health and reproductive rights using football as a point of connection Kai and Chi-Wei from Taiwan speaking about HIVStory Professor David Gere from the University of California speaking about his work as Co-Director of Through Positive Eyes Maggie Czarnogorski, the Head of Digital Innovation and Implementation Science at ViiV Healthcare speaks about a virtual reality experience aiming to better educate people on the stigma and discrimination that people living with HIV face Check out our other JOY Podcasts for more on LGBTIQ+ health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at Thorne Harbour Health and in South Australia at SAMESH.

In this week's edition of the podcast, Isabel and Jade share an interview with Dr Harmony Garges, Chief Medical Officer, ViiV Healthcare. She speaks with Dr Jonathan Sackier, Host, EMJ Podcast, who joined us in Reuters Barcelona where we meet our guest. Together, the two discuss Harmony's decision to join the pharmaceutical industry, how treating children with HIV needs to be approached differently, her views on improving vital access to HIV treatment and much more. This is the longer version of her Catalyst interview with us, check that out here.

In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics covered include:Potential provider barriers to prescribing PrEPStrategies to facilitate conversations about PrEPAddressing the gap in PrEP provider trainingStructural barriers for PrEP coverage, such as lack of insurance and complexity of billingInformed consent for minorsCDC guidelines on HIV testing and renal or lipid monitoring while on PrEPThe role of PrEP champions or PrEP navigators, such as in the SNAPS PrEP Navigation ProgramSolutions to common problems with PrEP persistence, such as use of telehealth and same-day PrEP initiationExpanding PrEP optionsPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including:Targeting key populations that would benefit from PrEP but have low rates of uptake, such as transgender women and people who inject drugsAddressing intersectionalityOvercoming implicit biasAddressing PrEP inequity by geographic regionExpanding PrEP uptake by expanding HCPs who prescribe itImproving PrEP education for both patients and HCPsPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include:Individual and community perspectives on PrEP barriersKey barriers by principal populationsStrategies to support PrEP deliveryPrEP options for key populationsPrEP efficacy based on adherence in cisgender men and womenComparing FTC/TDF vs FTC/TAF or CAB for PrEPPrEP in pregnancy and breastfeedingDrug–drug interactions with gender-affirming hormone therapyPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including:New data surrounding long-acting ART, including:The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approachThe IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIVThe ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to oral ARTUpdated data from San Francisco's Ward 86 Clinic using LA CAB + RPV in people without viral suppression at baselineCase series of LA CAB (± RPV) + LEN for select people living with HIV unable to take oral ART and unable to use LA CAB + RPV aloneData on comorbidities and coinfections, including:A REPRIEVE proteomic analysis to elucidate mechanistic pathways of statin effects on plaqueThe ACTG A5371 SLIM LIVER study of semaglutide for MASLD in people living with HIVThe impact of Doxy-PEP guideline implementation on STIs in men who have sex with men and transgender women in San FranciscoPotential novel treatment options on the horizon for people living with HIV, including:Phase II data on LEN + ISL dosed orally once weeklyEarly data on other oral weekly optionsData on bNAbs in combination or with other ART agentsPresenters:Joseph J. Eron, Jr., MDProfessor of Medicine, School of MedicineHerman and Louise Smith Distinguished ProfessorChief, Division of Infectious DiseasesDirector, Clinical Core, UNC Center for AIDS ResearchAdjunct Professor of EpidemiologyGillings School of Global Public HealthUniversity of North Carolina at Chapel HillChapel Hill, North CarolinaMonica Gandhi, MD, MPHProfessor of MedicineDivision of HIV, Infectious Diseases, and Global MedicineMedical Director, Ward 86 HIV ClinicUniversity of California, San FranciscoSan Francisco, CaliforniaContent based on an online CME program supported by independent educational grants from Gilead Sciences; Merck & Co., Inc.; and ViiV Healthcare.Link to full program: https://bit.ly/4awdWJMGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts or Spotify.

ViiV Healthcare is the world's  only pharmaceutical company dedicated exclusively to HIV, and in this episode, Ben meets its CEO, Deborah Waterhouse, to explore the company's approach to HIV R&D and commercial success - as well as the controversies its global access strategy has attracted for its new long acting injectables. Deborah and Ben find they have much in common beyond both being Brits growing up in the 70s and 80s, from being students of the humanities choosing to make careers in health, to their favorite pop music.  https://viivhealthcare.com https://www.unaids.org/en https://www.who.int/health-topics/hiv-aids https://www.cdc.gov/hiv/default.html https://au.int/en/sa/oid #ViiV #pharma #HIV #AIDS #treatment #Prevention #PrEP #dualtherapy #longacting #injectables #globalaccess #globalequity #discrimination #positiveaction #womenleaders #IWD 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Hip Hop star DameZ is with us today, talking with us, and playing a track from his new album Hell Now, Heaven Later.  He is a rapper, singer, dancer, songwriter, editor, creative director, and a rising star in music. With a focus on on rap and and R&B, he showcases his talents and versatility through an eclectic catalog of self-penned songs and choreography-heavy visuals and performances. DameZ was named the “New Face of Atlanta's Music Scene” by Out Magazine's Pride edition in 2020, as well as Atlanta Magazine. In 2022, MTV News said Damez was ready to take the throne. He was featured on Billboard.com twice, as part of their ‘Billboard Pride' playlist for his 2019 singles “Pull Up” and “Big Mood.” He's performed for Atlanta's Black Pride Festival in 2019, 2021, & 2022, as well as other notable performances such as 2021's MOBI Fest, Human Rights Campaign's HBCU Summit in 2019, and opening for original Dreamgirl Jennifer Holliday during NAESM's 2020 Leadership Conference. An advocate for equal rights and healthcare, he has participated in numerous campaigns for brands such as CDC and PrEP, among others. Most recently, he was featured in a 2022 campaign alongside Tina Knowes-Lawson and more for ViiV Healthcare to end HIV stigma and raise awareness on preventive medication. With co-host Brody Levesque

Hip Hop star DameZ is with us today, talking with us, and playing a track from his new album Hell Now, Heaven Later.  He is a rapper, singer, dancer, songwriter, editor, creative director, and a rising star in music. With a focus on on rap and and R&B, he showcases his talents and versatility through an eclectic catalog of self-penned songs and choreography-heavy visuals and performances. DameZ was named the “New Face of Atlanta's Music Scene” by Out Magazine's Pride edition in 2020, as well as Atlanta Magazine. In 2022, MTV News said Damez was ready to take the throne. He was featured on Billboard.com twice, as part of their ‘Billboard Pride' playlist for his 2019 singles “Pull Up” and “Big Mood.” He's performed for Atlanta's Black Pride Festival in 2019, 2021, & 2022, as well as other notable performances such as 2021's MOBI Fest, Human Rights Campaign's HBCU Summit in 2019, and opening for original Dreamgirl Jennifer Holliday during NAESM's 2020 Leadership Conference. An advocate for equal rights and healthcare, he has participated in numerous campaigns for brands such as CDC and PrEP, among others. Most recently, he was featured in a 2022 campaign alongside Tina Knowes-Lawson and more for ViiV Healthcare to end HIV stigma and raise awareness on preventive medication. With co-host Brody Levesque

No mês em que se celebra o Dia Mundial da Luta Contra a SIDA, recebemos os convidados Emanuel Caires, que foi diagnosticado como VIH positivo aos 18 anos, e a Dra. Cristina Valente, diretora do Serviço de Infecciologia do Centro Hospitalar e Universitário de Coimbra. Com o apoio da ViiV Healthcare.

In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include:Available training resources on how to offer PrEP in primary careAffordable, accessible PrEP options, including patient assistance programsUsing electronic health records to identify candidates for PrEPOpportunities to offer PrEP during appointments regarding birth control, STIs, or any other sexual health concernsHow to offer 3-site STI testing at your facilityWrapping PrEP into primary careIncorporating navigators or care coordinators to reduce logistical barriers and reach underserved populationsRapid testing, mobile testing, and Tele-PrEP as ways to facilitate PrEP initiation and simplify routine PrEP visitsHealthcare professionals' personal biases as a potential barrier to PrEPUsing ICD-10 codes for HIV PrEP as a way to further destigmatize PrEP and simplify billingFaculty:Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANPDirector, HIV Prevention and TreatmentSt. Thomas Community Health CenterNew Orleans, LouisianaJona Tanguay, MMSc, PA-C, AAHIVSMedical Program Lead - Substance Use Disorders at Whitman-Walker HealthAssociate Medical Director - Transgender Health at Amida CarePresident-Elect at GLMA: Health Professionals Advancing LGBTQ+ EqualityClinical Instructor at Yale School of MedicineFounder at ChemsexHarmReduction.orgWashington, DCContent is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare.Link to full program: https://bit.ly/3PZGYdR

In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include:Methods for building trust between patients and providersWays to practice shared decision-making and how this process hinges on respecting patients' autonomy and personhoodHow to empower young people to ask for the assistance they needHow to navigate consent and confidentiality issuesInformation about payment optionsStrategies to improve adherence for youthThe best ways to provide support and flexibility throughout this process to promote persistence on PrEP Faculty:Errol L. Fields, MD, PhD, MPHAssociate Professor of PediatricsDivision of Adolescent/Young Adult MedicineDepartment of PediatricsJohns Hopkins School of MedicineBaltimore, MarylandArmonté Butler, MPHAssociate Director, LGBTQ Health & RightsAdvocates for YouthWashington, DCContent is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare.Link to full program: https://bit.ly/3PZGYdR

Esta noche, en Impacto Ahora, su presentadora favorita, Carolina Hidalgo, hace entrevistas exclusivas con la estrella del fútbol en ascenso Teo Guerra y la sensación del pop Jules. No se lo pierdan. Este capítulo fue escrito por Joel Perez y traducido por Tonatiuh y está protagonizado por las siguientes personas en orden de aparición: Brandon Contreras (Maquillador), Lisa Vidal (Carolina), Froy Gutiérrez (Teo), Cecilia Suárez (Cristina), Mateo Gómez (Pastor Francisco), Tonatiuh (Actor de PrEP), Marcel Ruiz (Jules), Tony Plana (Abuelo), Jessica Marie García (Isa) y Mateo Gómez (Hermes). Love in Gravity es presentado por ViiV Healthcare. La serie fue producida por Harley & Co. y dirigida por Ranada Shepard. Casting de X Casting/Víctor Vázquez, CSA. Con supervisión musical de Javier Nuño y Joe Rodríguez.

Jack O'Brien speaks with Dr. Maggie Czarnogorski, head of digital innovation and implementation science at ViiV Healthcare, about Chapters of Stigma, the virtual reality experience that acknowledges the stresses and micro-traumas that many people living with HIV still endure.Follow us: @MMMnewswww.mmm-online.com

Teo and Jules' worlds (and mothers) collide, secrets are revealed, and Teo tries something new. This episode was written by Daniel F. Pérez and stars the following people in order of appearance: Gina Torres (Gloria), Andrew Keenan-Bolger (Paul), Cecilia Suárez (Cristina), Froy Gutierrez (Teo), Brandon Contreras (Manny), Marcel Ruiz (Jules), and Kris D. Lofton (DeVonn). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

Teo and Jules try again. During a high-stakes game, the unthinkable happens and Jules rushes to be by Teo's side. This episode was written by Lilliam Rivera and stars the following people in order of appearance: Hamish Linklater (Hank), Taylor Misiak (Barbara), Froy Gutierrez (Teo), Marcel Ruiz (Jules), Kris D. Lofton (DeVonn), Jessica Marie Garcia (Isa), Silvia Dionicio (Natalie), Gina Torres (Gloria), Andrew Keenan-Bolger (Manny), and Cecilia Suárez (Cristina). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

In this podcast, experts Sarah M. Wood, MD, MS, and Errol L. Fields, MD, PhD, MPH, discuss some of the challenges and concerns clinicians face when prescribing PrEP to adolescents. The faculty addresses the potential for adverse effects from PrEP, including the potential for renal impairment, decreased bone density, and whether PrEP can interfere with hormone therapy for gender-affirming care. They review the data behind these concerns and emphasize that the vast majority of adverse effects caused by PrEP are mild and reversible.The experts also examine common barriers that adolescents face when attempting to initiate and adhere to PrEP, such as insurance coverage and confidentiality. Dr Fields and Dr Woods discuss strategies for overcoming these barriers and retaining adolescents on PrEP, including how to navigate tricky conversations with both patients and parents or within communities that may stigmatize PrEP and HIV.Sarah M. Woods, MD, MSAssistant Professor of PediatricsDivision of Adolescent MedicineUniversity of Pennsylvania Perelman School of MedicineChildren's Hospital of PhiladelphiaPhiladelphia, PennsylvaniaErrol L. Fields, MD, PhD, MPHAssociate Professor of PediatricsDivision of Adolescent/Young Adult MedicineDepartment of PediatricsJohns Hopkins School of MedicineBaltimore, MarylandContent based on an online CME program supported by independent educational grants from Gilead Sciences Inc. and ViiV Healthcare.Link to full program: https://bit.ly/3PZGYdR

In this episode, David Alain Wohl, MD, discusses key considerations to PrEP barriers in cisgender women, including:Prevalence of PrEP use in the USBarriers to PrEP uptake PrEP efficacy based on adherenceInterventions to support PrEP adherenceRecommended PrEP regimens, including considerations for use in pregnancy and breastfeeding Presenter: David Alain Wohl, MDProfessor of MedicineSchool of MedicineSite Leader, Global Infectious Diseases Clinical Trials UnitUniversity of North Carolina at Chapel Hill Chapel Hill, North Carolina Content based on an online CME program supported by an independent educational grant from ViiV Healthcare. Link to full program: https://bit.ly/3ZpM6uuFollow along with the slides: https://bit.ly/3LyGgBj

Teo is betrayed and Jules flees to Puerto Rico to recover. Teo finally lets his mother set him up and then turns to his best friend DeVonn for advice.  This episode was written by Daniel F. Pérez and stars the following people in order of appearance: Hamish Linklater (Hank), Taylor Misiak (Barbara), Marcel Ruiz (Jules), Froy Gutierrez (Teo), Lux Pascal (Sofia), Jake Borelli (Greg), Jessica Marie Garcia (Isa), Silvia Dionicio (Maddie), Tony Plana (Abuelo), Gina Torres (Gloria), Tonatiuh (Bomba Player), and Kris D. Lofton (DeVonn). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

Jules goes to New Orleans to meet Teo and tries to figure out what to do with Teo's big secret.   This episode was written by Joel Perez and stars the following people in order of appearance: Taylor Misiak (Barbara), Hamish Linklater (Hank), Jake Borelli (Greg), Jessica Marie Garcia (Isa), Andrew Keenan-Bolger (Waiter), Marcel Ruiz (Jules), Kris D. Lofton (DeVonn), Froy Gutierrez (Teo), Tonatiuh (Tour Guide), Yunior Reyes (Teammate), Gina Torres (Gloria), and Cecilia Suárez (Cristina). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

Jules and Teo meet in the most unexpected of ways during one of the biggest nights of both of their careers.  This episode was written by R.K. Russell and stars the following people in order of appearance: Hamish Linklater (Hank), Taylor Misiak (Barbara), Kris D. Lofton (DeVonn), Froy Gutierrez (Teo), Marcel Ruiz (Jules), Andrew-Keenan Bolger (Concession Guy), Jake Borelli (Greg), Yunior Reyes (Kings Quarterback), and Jessica Marie Garcia (Isa). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

Intrigued by Teo, Jules follows him to a party and makes his move. The next day, Teo heads home to Texas while Jules flies to Miami and we meet… the mothers.  This episode was written by Lilliam Rivera and stars the following people in order of appearance: Froy Gutierrez (Teo), Marcel Ruiz (Jules), Hamish Linklater (Hank), Taylor Misiak (Barbara), Andrew Keenan-Bolger (Waitstaff), Silvia Dionicio (Emily), Kris D. Lofton (DeVonn), Gina Torres (Gloria), Mateo Gomez (Pastor Francisco), Cecilia Suárez (Cristina), and Yunior Reyes (Travis). Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.

In this episode, Roger Bedimo, MD, MS, FACP, discusses key considerations to PrEP barriers in adolescents, including: New HIV diagnoses in the United StatesAdherence barriersHealthcare professional barriersConsent laws for minors to receive sexually transmitted infection diagnosis and treatment services Interventions to support PrEP adherence Presenter: Roger Bedimo, MD, MS, FACPProfessor of MedicineDivision of Infectious DiseasesUniversity of Texas UT Southwestern Medical CenterSection ChiefDepartment of Internal MedicineVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ZpM6uuFollow along with the slides:https://bit.ly/3LyGgBj

The acclaimed podcast returns for Season 2 – launching October 5th, 2023, and releasing weekly. This season, Jules and Teo meet unexpectedly at one of the biggest moments of their lives – each on the cusp of stardom, exposed to the world and in the process of becoming, they fight to find what they need to be for themselves, for each other, for their families, and for their fans.  Love in Gravity, presented by ViiV Healthcare, is an original series starring Marcel Ruiz & Froy Gutierrez, with Cecilia Suárez, and Gina Torres. The series also stars, in order of appearance: Hamish Linklater, Taylor Misiak, Kris D. Lofton, Jake Borelli, Jessica Marie Garcia, Lux Pascal, Tony Plana, Lisa Vidal, and more. Love in Gravity is presented by ViiV Healthcare. The show is produced by Harley & Co. and directed by Ranada Shepard. Casting by X Casting/ Victor Vazquez, CSA. Music supervision by Javier Nuño and Joe Rodríguez.  Season 2's episodes were written by R.K. Russell, Lilliam Rivera, Joél Pérez, Daniel F. Perez, and translated by Tonatiuh. Subscribe now and be the first to listen to #LoveInGravity.

In this episode, Nikos Dedes, Jeff Taylor, and Bernadette Sharp—people living with HIV—discuss how switching to long-acting ART has affected their quality of life. They are joined by 2 healthcare professionals—Iskandar Azwa,MBChB, MRCP, and Beng Eu, MBBS—who provide insights on how they assess and document health-related quality of life for their patients. The discussion focuses on personal experiences with how LA ART has improved health-related quality of life, including:Avoidance of drug–drug interactionsImproved confidentiality Decreased stigmaPresenters:Iskandar Azwa, MBChB, MRCPAssociate ProfessorInfectious DiseasesFaculty of MedicineUniversity of MalayaKuala Lumpur, MalaysiaNikos DedesPositive VoiceAthens, GreeceBeng Eu, MBBSDoctorPrahran Market Clinic Melbourne, Victoria, AustraliaBernadette SharpAdvocateJeff TaylorExecutive DirectorHIV+Aging Research ProjectPalm Springs, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.Link to downloadable slides: https://bit.ly/488WwT7Link to full program: bit.ly/3EwEnRJ

In this episode, Iskandar Azwa, MBChB, MRCP; Nikos Dedes; Beng Eu, MBBS; Bernadette Sharp; and Jeff Taylor discuss challenges and opportunities with long-acting ART implementation, including:Personal experiences with receiving LA ART Views on long-acting ART in the development pipelinePerspectives on self-administration of LA ARTPresenters:Iskandar Azwa, MBChB, MRCPAssociate ProfessorInfectious DiseasesFaculty of MedicineUniversity of MalayaKuala Lumpur, MalaysiaNikos DedesPositive VoiceAthens, GreeceBeng Eu, MBBSDoctorPrahran Market Clinic  Melbourne, Victoria, AustraliaBernadette SharpAdvocateJeff TaylorExecutive DirectorHIV+Aging Research ProjectPalm Springs, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.Link to downloadable slides: https://clinicaloptions.com/CE-CME/infectious-disease/slides-fourth-90-and-la-art/17553-25368  Link to full program: https://bit.ly/3EwEnRJ

This week on the CBS News Weekend Roundup with host Stacy Lyn, former President Trump was in court for his third indictment. CBS's Natalie Brand has the details and our Scott MacFarlane gives us a look inside the courtroom. Correspondent Jonathan Vigliotti has the latest on a woman who was abducted and locked up in a makeshift cinderblock cell in a garage in Oregon. And in the Kaleidoscope, Stacy Lyn talks about the rise in HIV cases among black women with Dr. Toyin Nwafor, the Senior Medical Director for HIV Prevention at ViiV Healthcare, See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, and Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discuss key considerations to barriers to PrEP uptake, including:Limited data on “on-demand” PrEP in cisgender women Strategies on improving communication with non‒English-speaking populations Role of pharmacists with injectable PrEP CDC PrEP guideline recommendations on routine HIV-1 RNA testing Engaging with pregnant persons who might want access to PrEP in the pharmacy settingOral PrEP efficacy based on adherence in cisgender women, including recent data presented at CROI 2023 by Marrazzo and colleaguesPresenters: Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCPAssociate ProfessorDepartment of Pharmacy PracticeMidwestern University College of Pharmacy, Downers Grove CampusDowners Grove, IllinoisSystem-Level HIV/ID Clinical PharmacistAmbulatory PharmacyNorthwestern MedicineWheaton, IllinoisKevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCESAssistant ProfessorDepartment of Pharmacotherapy and Clinical ResearchUniversity of South FloridaClinical PharmacistTampa General Medical GroupTampa, FloridaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ZjSFhgDownloadable slides: https://bit.ly/3PsFNDt

This week on Pharm5: Ivermectin fails against COVID-19 Cabenuva noninferior to Biktarvy Syfovre for geographic atrophy Aspirin for pre-eclampsia prevention TRUNCATE-TB results could shorten TB treatment Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Naggie S, Boulware DR, Lindsell CJ, et al. Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with covid-19. JAMA. February 2023. doi:10.1001/jama.2023.1650. Efficacy: Cabenuva (cabotegravir; Rilpivirine). Efficacy: Every 2 Month | CABENUVA Official HCP Website. http://bit.ly/3kpnkdU. Accessed February 23, 2023. VIIV healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, Rilpivirine) is as effective as daily oral biktarvy (BIC/FTC/TAF) for the treatment of HIV-1. ViiV Healthcare. http://bit.ly/3m14uKy. Accessed February 23, 2023. Low-dose aspirin use for the prevention of preeclampsia and related morbidity and mortality. ACOG. http://bit.ly/3kuekE7. Accessed February 23, 2023. Mendoza M, Bonacina E, Garcia-Manau P. Aspirin discontinuation at 24 to 28 weeks' gestation in pregnancies a high risk of preterm preeclampsia: a randomized clinical trial. JAMA. February 2023. doi: 10.1001/jama.2023.0691. FDA Oks first drug for geographic atrophy, a major cause of adult blindness. FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness. http://bit.ly/3ZgFwoE. Published February 17, 2023. Accessed February 22, 2023. Paton NI, Cousins C, Suresh C, et al. Treatment strategy for rifampin-susceptible tuberculosis. New England Journal of Medicine. 2023. doi:10.1056/nejmoa2212537 Treatment for TB disease. Centers for Disease Control and Prevention. http://bit.ly/3Y5HxTW. Published March 7, 2022. Accessed February 23, 2023.

Ben and Yvette have a rather vigorous but hugely engaging conversation with friend of the Pod, Dr. Kimberly Smith, the Head of R&D for ViiV Healthcare, on what's needed to ensure that the potential of long acting injectable antiretrovirals - for both HIV prevention & treatment - are realized for girls and women in sub-Saharan Africa. With its costs and manufacturing complexity - will CabLA be a truly a game changer or an afterthought? And Kim promised to check whether the regulatory submission formulation of long-acting cabotegravir and rilpivirine for treatment has been filed in South Africa already: It was, in September 2021.  https://www.croiconference.org https://www.ashotinthearmpodcast.com https://viivhealthcare.com https://www.avac.org https://apha.org.za https://medicinespatentpool.org https://www.niaid.nih.gov https://www.cdc.gov https://www.iasusa.org https://www.unaids.org https://www.state.gov/pepfar #CROI_2023 #HIV #prevention #treatment #longacting #CabLA #vaccine #pandemics #access #affordability #techtransfer #voluntarylicense